Here are relevant reports on : clinical-documentation-improvement-market
-
Cognitive Assessment and Training in Healthcare Market by Assessment Type (Pen-and-Paper Based, Hosted, and Biometrics), Components, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), & Region - Global forecast to 2021
Cognitive impairment can occur in early childhood or late adulthood. There are various reasons for it, which can be reversible or irreversible. Early causes may include malnutrition, prenatal drug exposure, genetic syndromes, and chromosome abnormalities. The brain retains its neuroplasticity till late adulthood; therefore, there has been a growing demand for cognitive assessment and training. MarketsandMarkets predicts the global cognitive assessment and training in healthcare market to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. The year 2015 has been considered as the base year, while the forecast period is 2016–2021.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Animal Protein Ingredients Market By Type (Dairy, Egg, Gelatin), Application (Dairy, Clinical Nutrition, Dietetic & Sports Food, Confectionery, Beverages, Meat, Bakery), By Geography: Trends & Forecasts To 2018
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Antimicrobial Susceptibility Testing Market by Product (Manual (Disk, Strip, Plate), Automated, Molecular), Method (e-test, Disk & Agar Diffusion, Genotypic), Type (Antibacterial, Antifungal), Application (Clinical, Epidemiology) Global Forecasts to 2029
The global antimicrobial susceptibility testing market, valued at US$4.28 billion in 2023, stood at US$4.45 billion in 2024 and is projected to advance at a resilient CAGR of 5.0% from 2024 to 2029, culminating in a forecasted valuation of US$5.68 billion by the end of the period. Major driving factors for market growth include the increasing prevalence of antibiotic-resistant infections and a greater demand for effective treatments.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030
The global clinical trial supplies market, valued at US$4.85 billion in 2024, stood at US$5.34 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$8.18 billion by the end of the period. The growing complexity of clinical trials, particularly with decentralized and adaptive trial designs, has heightened the demand for efficient supply chain management solutions.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Computer Assisted Coding Market by Software (Natural Language Processing, Structured Input, Integrated Systems), Service (Support, Education & Training), Application (Automated Encoding, Clinical Coding Audit, Management Reporting) - Global Forecast to 2022
The global computer-assisted coding market is valued at USD 2.76 Billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 Billion by 2022. In 2016, 3M Company (U.S.) and Optum, Inc. (U.S.) dominated the global computer-assisted coding market. Some of the prominent players in the market are Nuance Communications, Inc. (U.S.), Cerner Corporation (U.S.) and Artificial Medical Intelligence, Inc. (U.S.). Some of the other leading players in this market are Dolbey Systems, Inc. (U.S.), Precyse Solutions, LLC (U.S.), Craneware plc (U.K.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Streamline Health Solutions, Inc. (U.S.), MMODAL IP LLC (M*Modal) (U.S.), TruCode (U.S.), Quest Diagnostics Inc. (U.S.), and Epic Systems Corporation(U.S.).
- Published: July 2017
- Price: $ 4950
- TOC Available:
-
Companion Animal Diagnostic Market by Product (Consumable, Instrument), Technology (Immunodiagnostic, ELISA, PCR Test, Urinalysis, Hematology), Animal Type (Dog, Cat), Application (Clinical Pathology, Virology), End User - Global Forecast to 2031
The global Companion Animal Diagnostic market, valued at USD 3.29 billion in 2025, stood at USD 3.56 billion in 2026 and is projected to advance at a resilient CAGR of 8.7% from 2026 to 2031, culminating in a forecasted valuation of USD 5.40 billion by the end of the period. Factors driving the companion animal diagnostics market include the rising demand for rapid and accurate diagnostic testing, the rising use of advanced technologies such as molecular diagnostic tests and AI-based analyzers, and also the growing focus on preventive and early diagnostic testing for companion animals.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
The latin american flow cytometry market size is projected to reach USD 379 million by 2027, at a CAGR of 7.1% during the forecast period. Key players in this market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Cytek Biosciences, Inc. (US), and Luminex Corporation (US).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029
The global Digital PCR and qPCR market, valued at US$9.4 billion in 2023, stood at US$10.0 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$14.8 billion by the end of the period. Growth in the digital PCR (dPCR) and real-time PCR (qPCR) market can be attributed to factors such as the rising incidence and prevalence of target infectious diseases and genetic disorders, continuous advancements in PCR technologies, the role of PCR in biomarker discovery, and increased use of dPCR and qPCR technologies for point of care (POC) diagnostics.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Autoimmunity Diagnostics Market by Product (Consumables, Instruments), Test Type (Routine, Autoantibody, Inflammatory, Urinalysis Tests), Disease (RA, SLE, MS, IBD), End User (Clinical Laboratories, Hospitals & Clinics) - Global Forecast to 2031
The global autoimmunity diagnostics market, valued at US$5.26 billion in 2024, stood at US$5.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2031, culminating in a forecasted valuation of US$8.98 billion by the end of the period. The autoimmunity diagnostics market is consistently growing, fueled by several key factors. These include the rising prevalence of autoimmune disease, growing awareness about early and accurate diagnosis, increasing research activities, and rapid advancements in diagnostic technologies.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, Cardio, GI, OBGYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2030
The global near IR imaging market, valued at US$9.69 billion in 2023, stood at US$1.25 billion in 2025 and is projected to advance at a resilient CAGR of 10.6% from 2025 to 2030, culminating in a forecasted valuation of US$2.07 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
